HHS Orders Elusys Anthrax Treatment for Strategic National Stockpile
The Department of Health and Human Services has awarded Elusys Therapeutics a $25.2 million contract to supply an anthrax treatment for the country’s national repository of medical countermeasures for public health emergency use. HHS said Monday its Biomedical Advanced Research and Development Authority provided funds for the company to produce the Anthim monoclonal antibody injection as part of Project BioShield. Elusys will […] More